Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Population screening shows risk of inherited cancer and familial hypercholesterolemia in Oregon

The American Journal of Human Genetics(2023)10.1016/j.ajhg.2023.06.014Source: DataRank Database

Population screening shows risk of inherited cancer and familial hypercholesterolemia in Oregon is a research paper published in The American Journal of Human Genetics (2023). On theSindex it has a DataRank of 0.592. It has been cited 14 times, with 12 citing works in its 1-hop citation network.

N/A

0.592DataRank · unranked

Scored on demand from live citation data

Open Access14 citations · 12 citing works in its network

Download PDF

Cite:

Linked data & code

omim refseq nct doi

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (22 grants)Impact (FWCI 2.96)OA: bronzeTopics (39)IDs (PubMed, PMC, OpenAlex)Annotations (4)SDGs (2)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

DataRank Breakdown

Base Score 69%Citation Network 31%

Base Score Contribution

0.406

From this paper's citation signal

Citation Network Contribution

0.185

From 7 citing papers with measurable signal

Learn more about DataRank methodology →

Top 5 citers driving the network score

Ranked by each citer's contribution to N(p) — log1p(C_q) divided by its reference count — out of 12 citers.

Variant Detection in 3′ Exons of PMS2 Using Exome Sequencing Data
Journal of Molecular Diagnostics20242 citations25 referencesContributes 0.044
Feasibility and outcomes of the DNA Screen nationwide adult genomic screening pilot
Nature Health20264 citations39 referencesContributes 0.041
Using implementation science to evaluate a population-wide genomic screening program: Findings from the first 20,000 In Our DNA SC participants
The American Journal of Human Genetics20248 citations60 referencesContributes 0.037
Actionable genetic variants in 4,198 Scottish participants from the Orkney and Shetland founder populations and implementation of return of results
The American Journal of Human Genetics20257 citations63 referencesContributes 0.033
Reproductive Carrier Screening: Identifying Families at Risk for Familial Hypercholesterolemia in the United States
Circulation Genomic and Precision Medicine20242 citations37 referencesContributes 0.030

Authors (34)

Amiee Potter,Catherine C. Driscoll,Gregory Goh,John Letaw ORCID,Sarah McCabe

Live enrichment

PubMed:37506692 PMC:PMC10432140 OpenAlex:https://openalex.org/W4385358772

Cancer Early Detection Advanced Research Center, Knight Cancer Institute, Oregon Health and Science University

Grant: Full 2023-1729

National Institutes of Health

Grant: 1U01CA232819-01A1

Evaluation of Population Based Testing for HBOC and Lynch Syndromes

National Institutes of Health

Grant: 3P30CA-69553-13S9

National Institutes of Health

Grant: R25GM129840

National Institutes of Health

Grant: R25OD01496

National Institutes of Health

Grant: R25RR020443-05S1

National Institutes of Health

Grant: RR026008

National Institutes of Health

Grant: UL1RR024140-04S3

National Institutes of Health

Grant: UL1TR002369

Oregon Clinical and Translational Research Institute

Grant: 1UL1TR002369

NCI NIH HHS

Grant: P30 CA069533

NCRR NIH HHS

Grant: UL1 RR024140

NIH HHS

Grant: R25 OD010496

NCRR NIH HHS

Grant: R25 RR020443

NCRR NIH HHS

Grant: R25 RR026008

NCI NIH HHS

Grant: U01 CA232819

National Institutes of Health

Grant: 5R25RR020443-05

Teacher Institute for the Experience of Science

National Institutes of Health

Grant: 3UL1TR002369-04S2

Oregon Clinical and Translational Research Institute - The National COVID Cohort Collaborative (N3C)

National Institutes of Health

Grant: 3R25RR026008-03S1

How sure are you? Science, Biostatistics and Cancer Education

National Institutes of Health

Grant: 3R25GM129840-02S1

Biomedical workforce near-peer mentees support public education and participation in research

Oregon Health and Science University

Knight Cancer Institute, Oregon Health and Science University

FWCI

2.96

Citation Percentile

0.9%

Citation Trend

2023

2024

2025

2026

bronzeLicense: Elsevier Non-Commercial

journalhttp://www.cell.com/article/S0002929723002392/pdf

publisherhttp://www.cell.com/article/S0002929723002392/pdf

publisherhttps://api.elsevier.com/content/article/PII:S0002929723002392?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S0002929723002392?httpAccept=text/plain

journalhttps://doi.org/10.1016/j.ajhg.2023.06.014

Fields of Study

BRCA gene mutations in cancerGenomics and Rare DiseasesCancer Genomics and Diagnostics0301 basic medicine0303 health sciences03 medical and health sciencesHumansOregonEarly Detection of CancerGenetic TestingHyperlipoproteinemia Type IINeoplasms

MeSH Terms

Genetic TestingHumansHyperlipoproteinemia Type IINeoplasmsOregonEarly Detection of Cancer

Keywords

Genetic testingPopulationMedicineMedical geneticsTest (biology)DNA sequencingGeneticsBiologyGeneEnvironmental healthInternal medicineInherited CancerFamilial HypercholesterolemiaPopulation ScreeningClinical Genetic TestingLaboratory GeneticsHyperlipoproteinemia Type IIOregonNeoplasmsHumansEarly Detection of Cancer

Sustainable Development Goals

SDG 3: 3. Good healthSDG 16: 16. Peace & justice